"Lawmakers are wrestling with how to translate complex hospital pricing data into actionable information for patients, with key bills diverging on whether online estimators or direct price listings should satisfy…
"After two decades of off-label use, the FDA’s approval of Lytenava for wet AMD signifies a crucial shift toward formalized safety and quality oversight for a widely used treatment, though…
"Athlete safety is paramount, and even the most anticipated finals must yield to the undeniable risks posed by severe weather, including heavy rain and lightning." The highly anticipated women’s singles…
"Scientists have identified a crucial molecular switch, a complex interplay between TRPV2 and CB2R receptors, that dictates how infection-fighting neutrophils are directed to sites of inflammation and, critically, how they…
"This venture fund represents a significant step in bridging the gap between promising technological innovation and real-world clinical application, though patients should understand these are developmental tools, not yet standard…
"Ohio’s top health official has declared a measles outbreak, marking the state’s third such event in seven months, underscoring the ongoing threat posed by the highly contagious virus, particularly among…
"A sevenfold increase in positive mosquito samples statewide, coupled with the season’s second human case, signals a critical juncture in Utah’s West Nile virus surveillance, underscoring the immediate need for…
"Sixteen days after its FDA approval, gedatolisib has been swiftly integrated into the National Comprehensive Cancer Network’s breast cancer treatment guidelines as a preferred Category 1 option, underscoring the drug’s…
"Prompt reporting of discomfort and a cautious, medically-guided approach are paramount for elite athletes like Shohei Ohtani, ensuring minor issues don’t escalate into significant injuries that jeopardize long-term performance." This…
"As open enrollment approaches, a significant portion of employees may find their employer-provided coverage for GLP-1 weight-loss medications altered, reflecting growing employer concerns about cost and utilization, even as per-unit…
